- Language: English
- 60 Pages
- Published: March 2013
- Region: Global
Global Pneumococcal Vaccine Market 2011-2015
- Published: September 2012
- Region: Global
- 34 pages
- Infiniti Research Limited
TechNavio's analysts forecast the Global Pneumococcal Vaccine market to grow at a CAGR of 18 percent in terms of revenue over the period 2011-2015. One of the key factors contributing to this market growth is the increase in the aging population. The Global Pneumococcal Vaccine market has also been witnessing the trend of the increase in market consolidation. However, the emergence of regional players could pose a challenge to the growth of this market.
TechNavio's research report, the Global Pneumococcal Vaccine Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Pneumococcal Polysaccharide Vaccines and Pneumococcal Conjugate Vaccines market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include GlaxoSmithKline plc. Merck and Co. Inc. and Pfizer Inc.
Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report. SHOW LESS READ MORE >
01. Executive Summary
03. Market Coverage
04. Market Landscape
Segmentation of Pneumococcal Vaccine Market
04.1 Five Force Analysis
05. Geographic Segmentation
06. Rate of Incidence and Prevalence
07. Vendor Landscape
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and Their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Key Vendor Analysis
14.1 Pfizer Inc.
14.2 GlaxoSmithKline plc
14.3 Merck and Inc.
15. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Pneumococcal Vaccine Market by Product Segmentation
Exhibit 2: Global Pneumococcal Vaccine Market 2011-2015 (US$ million)
Exhibit 3: Global Pneumococcal Vaccine Market by Product Segmentation 2011(percent)
Exhibit 4: Global Pneumococcal Vaccine Market by Geographical Segmentation 2011
Exhibit 5: Global Pneumococcal Vaccine Market by Vendor Segmentation 2011
TechNavio Announces the Publication of its Report - Global Pneumococcal Vaccine Market 2011-2015
TechNavio today launched its report Global Pneumococcal Vaccine Market 2011-2015 based on an in-depth study covering the Americas, and the EMEA and the APAC regions. The report aims to aid decision makers' understanding of the significant trends impacting this market.
Commenting on the report, an analyst from TechNavio's Healthcare team said: ''The vendors in the market have started targeting the elderly population in the developing nations in order to increase their market share in those countries. Moreover, there is large unmet demand for vaccines in developing nations. Furthermore, companies are planning to launch various vaccines in emerging markets in the near future to target the aging population along with the child population.''
According to the report, the increased awareness about and accessibility to pneumococcal vaccines in developing nations, where incidence and prevalence of pneumococcal diseases are comparatively higher than the developed nations, is one of the key drivers for the growth of the market.
Further, the report discusses that one of the key challenges is the emergence of regional players in developing countries, particularly in India and China.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.